Kleptomania is classified in the International Classification of Diseases of the World Health Organization (WHO) ICD-10 (Code F63.2) under the heading of habit and impulse disorders together with pathological gambling, pyromania, and trichotillomania. Individuals with kleptomania typically suffer from emotional distress and/or impaired functioning in social and occupational areas. Kleptomania has occasionally been reported to stem from neurological disorders. The emotional distress, stress, potential marital conflict, arrests, and jail time associated with kleptomania undoubtedly diminish patients' quality of life (QOL). Kleptomania patients are highly likely to suffer from comorbid psychiatric disorders, most notably mood disorders, anxiety disorders, eating disorders, other impulse control disorders, and alcohol and other psychoactive substance abuse/dependence disorders. Clonazepam and alprazolam have been reported to produce partial success in treating kleptomania. Over the past 50 years, the treatment approach toward kleptomania has shifted away from psychodynamic therapy. Cognitive-behavioral interventions have been reported to help in individual cases.